Single and chronic administration of cellulose ethers rescue memory deficit in a transgenic mouse model of Alzheimer’s disease

Alzheimer’s disease (AD) is an incurable neurodegenerative disease and the major cause of dementia. Recent studies including our findings showed that cellulose ethers (CEs) derivative (TC‐5RW) treatment as a single subcutaneous (SC) dose (4g/kg) have therapeutic effects in neurodegenerative diseases via inhibiting the aggregation of misfolded proteins such as prions and amyloid beta (Aβ). CEs are approved by the FDA as safe, inactive ingredients in foods and pharmaceuticals. Therefore, in this study we aimed to test whether single and repeated treatment with the CE TC‐5RW improves cognitive functions in an animal model of AD.